652 Results

People

  1. Offit
    Offit
  2. Orlow
    Orlow
  3. Cordon-Cardo
    Cordon-Cardo
  4. Ladanyi
    Ladanyi
  5. Olson
    Olson
  6. Begg
    Begg
  7. Robson
    Robson
  8. Levine
    Levine
  9. Dupont
    Dupont
  10. Kirchhoff
    Kirchhoff

Groups

  1. GSK Faculty (258)
  2. Department of Medicine (252)
  3. Population Sciences Research Program (160)
  4. Solid Tumor Oncology Division (152)
  5. Sloan Kettering Institute Faculty (144)
  6. Department of Pathology and Laboratory Medicine (135)
  7. Epidemiology and Biostatistics (132)
  8. Survivorship Research (116)
  9. Surgery (110)
  10. Tow Center for Developmental Oncology (TCDO) (108)
  1. "genotype"
Formats
  1. Journal Article (627)
  2. Review (9)
  3. Meeting Abstract (6)
  4. Research Letter (5)
  5. Editorial (2)
  6. Conference Paper (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. GSK Faculty (258)
  2. Department of Medicine (252)
  3. Population Sciences Research Program (160)
  4. Solid Tumor Oncology Division (152)
  5. Sloan Kettering Institute Faculty (144)
  6. Department of Pathology and Laboratory Medicine (135)

More Groups

People
  1. Kenneth Offit (62)
  2. Irene Orlow (38)
  3. Carlos Cordon-Cardo (28)
  4. Marc Ladanyi (27)
  5. Sara Olson (24)
  6. Colin Begg (22)

More People

Years
  1. 2025 (16)
  2. 2024 (29)
  3. 2023 (14)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (24)

More Years

Publications
  1. Clinical Cancer Research (31)
  2. Proceedings of the National Academy of Sciences of the United States of America (24)
  3. Cancer Epidemiology Biomarkers and Prevention (22)
  4. Cancer Research (22)
  5. Nature Genetics (21)
  6. JNCI: Journal of the National Cancer Institute (13)

More Publications

Publishers
  1. American Association for Cancer Research (86)
  2. Nature Publishing Group (78)
  3. Elsevier Inc. (57)
  4. Oxford University Press (38)
  5. Wiley Blackwell (33)
  6. Springer (32)

More Publishers

Results (652)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Lack of p53 nuclear immunostaining is not indicative of absence of TP53 gene mutations in colorectal adenocarcinomas
    Journal Article

    Colomer, A.; Erill, N.; Verdú, M.; Roman, R.; Vidal, A.; Cordon-Cardo, C.; Puig, X.
    Applied Immunohistochemistry & Molecular Morphology (2003)

    Fulltext@MSK | Save
  • Unique de novo mutation of BRCA2 in a woman with early onset breast cancer
    Journal Article

    Robson, M.; Scheuer, L.; Nafa, K.; Ellis, N.; Offit, K.
    Journal of Medical Genetics (2002)

    Fulltext@MSK | Save
  • The killer cell immunoglobulin-like receptor (KIR) genomic region: Gene-order, haplotypes and allelic polymorphism
    Journal Article

    Hsu, K. C.; Chida, S.; Geraghty, D. E.; Dupont, B.
    Immunological Reviews (2002)

    Fulltext@MSK | Save
  • Allogeneic bone marrow transplantation for chronic myelogenous leukemia: Comparative analysis of unrelated versus matched sibling donor transplantation
    Journal Article

    Weisdorf, D. J.; Anasetti, C.; Antin, J. H.; Kernan, N. A.; Kollman, C.; Snyder, D.; Petersdorf, E.; Nelson, G.; McGlave, P.
    Blood (2002)

    Fulltext@MSK | Save
  • Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo
    Journal Article

    Trcka, J.; Moroi, Y.; Clynes, R. A.; Goldberg, S. M.; Bergtold, A.; Perales, M. A.; Ma, M.; Ferrone, C. R.; Carroll, M. C.; Ravetch, J. V.; more...
    Immunity (2002)

    Fulltext@MSK | Save
  • Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations
    Journal Article

    Satagopan, J. M.; Boyd, J.; Kauff, N. D.; Robson, M.; Scheuer, L.; Narod, S.; Offit, K.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Fission yeast CENP-B homologs nucleate centromeric heterochromatin by promoting heterochromatin-specific histone tail modifications
    Journal Article

    Nakagawa, H.; Lee, J. K.; Hurwitz, J.; Allshire, R. C.; Nakayama, J. I.; Grewal, S. I. S.; Tanaka, K.; Murakami, Y.
    Genes and Development (2002)

    Fulltext@MSK | Save
  • The use of molecular markers in farnesyltransferase inhibitor (FTI) therapy of breast cancer
    Journal Article

    Moasser, M. M.; Rosen, N.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • A target essential for the activity of a nonacidic yeast transcriptional activator
    Journal Article

    Lu, Z.; Ansari, A. Z.; Lu, X.; Ogirala, A.; Ptashne, M.
    Proceedings of the National Academy of Sciences of the United States of America (2002)

    Fulltext@MSK | Save
  • Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods
    Journal Article

    Lu, M. L.; Wikman, F.; Orntoft, T. F.; Charytonowicz, E.; Rabbani, F.; Zhang, Z.; Dalbagni, G.; Pohar, K. S.; Yu, G.; Cordon-Cardo, C.
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save